Provided by Tiger Trade Technology Pte. Ltd.

QYUNS-B

16.530
+0.2901.79%
Volume:1.60M
Turnover:27.15M
Market Cap:3.69B
PE:10.03
High:17.770
Open:16.000
Low:16.000
Close:16.240
52wk High:36.500
52wk Low:13.210
Shares:223.00M
HK Float Shares:223.00M
Volume Ratio:34.84
T/O Rate:0.72%
Dividend:- -
Dividend Rate:- -
EPS(LYR):1.648
ROE:101.58%
ROA:22.80%
PB:3.66
PE(LYR):10.03
PS:3.08

Loading ...

QYUNS Deploys RMB270.00 Million Idle Funds into Low-Risk Structured Deposits at Shanghai Pudong Development Bank

Bulletin Express
·
Apr 29

QYUNS-B (02509) Allocates Funds to Wealth Management Products

Stock News
·
Apr 29

Qyuns Therapeutics Co Ltd - to Subscribe Pdb Wealth Product With RMB100 Mln Principal Maturing Oct 29, 2026

THOMSON REUTERS
·
Apr 29

Qyuns Therapeutics 2025年业绩大幅增长并实现首次全年盈利,全球化布局与核心产品管线齐头并进

Bulletin Express
·
Apr 27

QYUNS-B Shares Surge Over 8% Following Turn to Profit Last Year; Projected Sales of Key Product Near RMB 500 Million This Year

Stock News
·
Apr 15

QYUNS-B Reports Stable Share Capital and Confirms Public Float Compliance for March 2026

Bulletin Express
·
Apr 09

Shareholders Will Be Pleased With The Quality of Qyuns Therapeutics' (HKG:2509) Earnings

Simply Wall St.
·
Apr 04

Qyuns Therapeutics Forms Strategy and Development Committee to Sharpen Long-Term Planning

TIPRANKS
·
Mar 27

QYUNS-B Reports Over 400% Revenue Surge in 2025, Swings to Adjusted Profit of 356 Million Yuan

Stock News
·
Mar 27

Qyuns Therapeutics - FY Revenue RMB807 Mln

THOMSON REUTERS
·
Mar 27

Qyuns Therapeutics Invests 100 Million Yuan in Wealth Management Product

MT Newswires Live
·
Mar 24

BRIEF-Qyuns Therapeutics Co To Subscribe For PDB Wealth Management Product With RMB100 Million Principal

Reuters
·
Mar 23

QYUNS-B (02509) Invests 100 Million Yuan in Wealth Management Product

Stock News
·
Mar 23

Qyuns Therapeutics Co Ltd - to Subscribe for Pdb Wealth Management Product With RMB100 Mln Principal

THOMSON REUTERS
·
Mar 23